Advancing cancer care with digital therapeutics that put patients first.

A oncology patient with a headscarf leaning close to a young girl, smiling and sharing a happy moment indoors near a window.
Healthcare professional consulting with a patient in a medical setting showing CascaDTx oncology digital therapeutics.

Cancer care is more than treatment alone.

Patients and families undergoing cancer treatment face side effects, emotional strain, and frequent hospital visits. Clinicians lack necessary day-to-day visibility, while health systems bear rising costs from avoidable complications.

CascaDTx develops AI-powered digital therapeutics that make cancer care more complete. With a patient-friendly app, connected devices, and a caregiver dashboard, we help patients, families, and clinicians stay connected and supported throughout treatment.

CascadTx oncology digital therapeutics app used by a healthcare provider to show a patient results.
Person wearing a smartwatch on their wrist which is connected to CascaDTx digital therapeutics solution platform.

What are Digital Therapeutics?

Digital therapeutics (DTx) are clinically proven software-based treatments that complement traditional cancer care. Unlike wellness apps, they are tested in trials, reviewed by regulators, and trusted by clinicians.

CascaDTx is building the next generation of oncology digital therapeutics: a complete software platform powered by AI.

Why we’re different: Unlike wellness apps or simple sympton trackers, CascaDTx integrates cutting-edge AI with clinical rigor, creating a therapy-first digital companion that completes cancer care.

Want to learn more about us or DTx?